I'm not a big fan of congress, but I'm curious what specifically they should be doing in this case ... does the FDA have a huge backlog/under-funding that is expected to hold up approval?
If so, is there any indication which way things could go? ... I'm admittedly not very knowledgeable about this area, so any further details into your thinking is appreciated.